To evaluate the dose-effect relation and efficacy by using chuanxiongchatiaosan, comprised of the different processed products of the rhizome of chuanxiong to treat the wind-attacking-type migraine

Phase 1

• Conditions: migraine

• Registration Number: ITMCTR2000002926
• Lead Sponsor: Beijing University of Chinese Medicine Third affiliated Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Patients are 18 to 70 years of age with a diagnosis of migraine according to western and TCM criteria, and had experienced 2 times per month in the past 3 months;
2. No preventive drugs were used before the attack, and no other traditional Chinese medicine or western medicine was used during the attack;
3. All patients participating to the clinical trial are voluntary and provide the written informed consent.

Exclusion Criteria

1. Pregnant or nursing women;
2. Patients do not conform to the diagnosis of migraine according to the western and TCM criteria;
3. Patients suffer from other diseases, such as heart, liver, kidney, hematopoietic system and other serious primary diseases, cancers or mental diseases;
4. Headache is one of the symptoms of other diseases, such as hypertension, post-traumatic brain syndrome and organic lesions in the brain, poisoning, or systemic disease;
5. Preventive drugs were used before the attack, or other traditional Chinese medicine or western medicine was used during the attack.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Visual Analogue Score;

Secondary Outcome Measures

Name	Time	Method
TCM syndrome comprehensive score;pittsburgh sleep quality index;headache impact test-6;